Equities

CI Medical Co Ltd

3540:TYO

CI Medical Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)1,064.00
  • Today's Change14.00 / 1.33%
  • Shares traded26.80k
  • 1 Year change+56.70%
  • Beta1.5699
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,8041,8263,681
Total Receivables, Net6,6684,3783,797
Total Inventory8,5877,2266,169
Prepaid expenses709552715
Other current assets, total809287
Total current assets17,84814,07414,449
Property, plant & equipment, net20,47013,8314,153
Goodwill, net546619--
Intangibles, net1,2501,088743
Long term investments1,035186223
Note receivable - long term------
Other long term assets81110102
Total assets41,50630,18619,915
LIABILITIES
Accounts payable1,7261,7301,481
Accrued expenses31248.00
Notes payable/short-term debt17,1007,0000
Current portion long-term debt/capital leases2927--
Other current liabilities, total1,9832,6352,030
Total current liabilities20,86911,4163,519
Total long term debt64650
Total debt17,1937,0920
Deferred income tax------
Minority interest8063--
Other liabilities, total434425419
Total liabilities21,44711,9693,938
SHAREHOLDERS EQUITY
Common stock10.0010.0010.00
Additional paid-in capital------
Retained earnings (accumulated deficit)20,07918,24916,009
Treasury stock - common000
Unrealized gain (loss)(30)(42)(41)
Other equity, total00(1)
Total equity20,05918,21715,977
Total liabilities & shareholders' equity41,50630,18619,915
Total common shares outstanding505050
Treasury shares - common primary issue0.000.000.00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.